Coronary event by 33% suggested

all NS

all NS

all NS

all NS

Coronary event by 51% suggested

cardiac death by 43% suggested

All cause death by 43% suggested

all NS

cardiovascular events by 21% fully demonstrated

Myopathy by 568% adverse event

Adverse events by 36% adverse event

stroke (fatal and non fatal) by 24% suggested

Coronary event by 20% suggested

Coronary death and non fatal MI by 20% suggested

Non fatal MI by 21% suggested

all NS

All cause death by 67% suggested

Myopathy by 802% adverse event

Adverse events by 130% adverse event

Non fatal MI by 17% suggested

MACE by 20% fully demonstrated

cardiovascular events by 19% suggested

Coronary event by 31% suggested

Non fatal MI by 40% suggested

Coronary event by 28% fully demonstrated

stroke (fatal and non fatal) by 27% suggested

Coronary death and non fatal MI by 35% suggested

MACE by 20% suggested

all NS

all NS

MI (CK-MB >3x ULN at 6 and 12 hours after PCI) by 44% suggested

MI (troponin I >3x ULN at 6 and 12 hours after PCI) by 44% suggested

stroke (fatal and non fatal) by 71% suggested

MACE by 61% suggested

Non fatal MI by 64% suggested

all NS

all NS

Coronary event by 24% fully demonstrated

Coronary death and non fatal MI by 24% suggested

all NS

all NS

cardiovascular events by 17% fully demonstrated

Coronary event by 22% fully demonstrated

Coronary death by 21% fully demonstrated

Cardiovascular death by 21% suggested

stroke (fatal and non fatal) by 13% suggested

Coronary death and non fatal MI by 22% suggested

MACE by 18% suggested

Non fatal MI by 14% suggested

All cause death by 15% suggested

all NS

all NS

cardiovascular events by 25% suggested

Coronary event by 33% suggested

Coronary death by 47% suggested

MACE by 30% suggested

Coronary event by 23% fully demonstrated

cardiovascular events by 41% suggested

Cardiovascular death by 32% suggested

Coronary death and non fatal MI by 30% suggested

Non fatal MI by 30% suggested

all NS

all NS

all NS

all NS

cardiovascular events by 32% fully demonstrated

MACE by 32% fully demonstrated

Venous thromboembolism by 43% suggested

stroke (fatal and non fatal) by 37% suggested

Coronary event by 35% suggested

Coronary death and non fatal MI by 35% suggested

cardiac death by 26% suggested

Non fatal MI by 65% suggested

All cause death by 12% suggested

all NS

All cause death by 15% fully demonstrated

cardiovascular events by 26% suggested

Cardiovascular death by 20% suggested

stroke (fatal and non fatal) by 25% suggested

Coronary event by 27% suggested

Coronary death and non fatal MI by 26% suggested

Coronary death by 22% suggested

cardiac death by 41% suggested

Non fatal MI by 36% suggested

Rhabdomyolysis by 1667% adverse event

Non fatal MI by 14% suggested

all NS

all NS

all NS

all NS